IP Library › Assignment 062230/0050
Patent Assignment
Reel/Frame 062230/0050

Change of Name

Recorded: 2022-12-14 Pages: 5
Assignor
CUREVAC GMBH
Executed: 2015-09-17
Assignee
CUREVAC AG
PAUL-EHRLICH-STR. 15, TÜBINGEN, 72076, GERMANY
Covered Properties (4)
PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS
Application: 14/487,425 →
Publication: US 2015/0104476
PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS
Application: 14/994,913 →
Publication: US 2016/0129105
PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS
Application: 15/005,950 →
Publication: US 2016/0136259
PHARMACEUTICAL COMPOSITION CONTAINING A STABILISED mRNA OPTIMISED FOR TRANSLATION IN ITS CODING REGIONS
Application: 15/005,986 →
Publication: US 2016/0136301
Related Assignments (2)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Dec 14, 2022
From: VON DER MÜLBE, FLORIAN; HOERR, INGMAR; PASCOLO, STEVE
To: CUREVAC GMBH
Reel/Frame 062096/0684 →
Change of Name Dec 14, 2022
From: CUREVAC AG
To: CUREVAC SE
Reel/Frame 062133/0229 →